Agape ATP Corporation (NASDAQ:ATPC – Get Free Report) was the target of a large decrease in short interest in the month of October. As of October 30th, there was short interest totaling 1,922 shares, a decrease of 72.4% from the October 15th total of 6,964 shares. Based on an average daily volume of 15,669 shares, the days-to-cover ratio is currently 0.1 days. Currently, 0.2% of the shares of the stock are sold short.
Analysts Set New Price Targets
Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Agape ATP in a research report on Wednesday, August 19th. One investment analyst has rated the stock with a Sell rating. Based on data from MarketBeat.com, the company has a consensus rating of “Sell”.
Get Our Latest Analysis on Agape ATP
Agape ATP Stock Performance
NASDAQ:ATPC traded down $0.01 during trading hours on Friday, hitting $1.35. 3,925 shares of the company’s stock traded hands, compared to its average volume of 1,812,148. The firm has a market cap of $1.35 million, a P/E ratio of -1.80 and a beta of 0.55. Agape ATP has a twelve month low of $1.15 and a twelve month high of $73.50. The stock’s fifty day moving average price is $1.88 and its two-hundred day moving average price is $2.54.
Agape ATP (NASDAQ:ATPC – Get Free Report) last issued its earnings results on Friday, August 14th. The company reported $0.15 EPS for the quarter. The business had revenue of $0.01 million during the quarter. Agape ATP had a negative return on equity of 5.47% and a negative net margin of 85.94%.
About Agape ATP
Agape ATP Corporation is a health and wellness company focused on providing personalized healthcare-related services, wellness programs and nutritional products. Its offerings are designed to support preventive health management, healthy aging and overall well-being. The company serves customers primarily through its operations in Malaysia and has marketed products and services connected with health assessments, nutrition and lifestyle management. Its business model combines wellness consultations with health-oriented consumer products and services.
Read More
- Five stocks we like better than Agape ATP
- Game On: The Hidden Value in Take-Two’s Stock
- LightPath Technologies’ Record Backlog Highlights a Bigger Defense Opportunity
- A 10-Stock Strategy That Balances AI Growth With Cash Flow
- Firefly Aerospace Lights Up a High-Risk Space Opportunity
Receive News & Ratings for Agape ATP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agape ATP and related companies with MarketBeat.com's FREE daily email newsletter.
